Table 1.
Characteristics of the study subjects
| Variables | ||
| Sex [n (%)] | ||
| Male | 139 (63.8) | |
| Female | 79 (36.2) | |
| Age Group [n (%)] | ||
| 35–39 | 42 (19.3) | |
| 40–49 | 64 (29.4) | |
| 50–59 | 72 (33.0) | |
| 60–69 | 40 (18.3) | |
| Genotype Frequency | ||
| CPT1B G320D | ||
| G/G | 216 (99.1) | |
| A/G | 2 (0.9) | |
| A/A | 0 (0.0) | |
| CPT1B S427C | ||
| G/G | 63 (28.9) | |
| C/G | 110 (50.5) | |
| C/C | 45 (20.6) | |
| CPT1B c.282-18 C>T | ||
| C/C | 62 (28.4) | |
| T/C | 105 (48.2) | |
| T/T | 51 (23.4) | |
| CPT1B p.E531K | ||
| G/G | 62 (28.4) | |
| A/G | 104 (47.7) | |
| A/A | 52 (23.9) | |
| CPT2 V368I | ||
| A/A | 110 (50.5) | |
| A/G | 89 (91.3) | |
| G/G | 19 (8.7) | |
| Plasma carnitine [mean (sd)] | ||
| 35.9 (10.4) | ||
| Serum creatinine [mean (sd)] | ||
| 0.782 (0.172) |
sd: standard deviation